Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04573426 · ClinicalTrials.gov registry record
Pain and Acetaminophen in Women Study
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 200
- Enrollment target
NCT04573426: Completed study, sponsored by Ohio State University.
NCT04573426 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04573426 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the influence of acetaminophen on pain response and inflammation.
Primary Outcome
Prostaglandin level (measured via PGE2) will be assessed via saliva and will be utilized as an objective marker of baseline inflammation Baseline prostaglandin level will be determined by analyzing saliva collected within the first ten minutes of the single, two-hour session.
Interventions
- DRUG Placebo
- DRUG Acetaminophen
- BEHAVIORAL Weight stigma vignette
- BEHAVIORAL Control vignette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2021-05-02 |
What the finished NCT04573426 record still lists
NCT04573426 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT04573426 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04573426 about?
NCT04573426 is a clinical study titled "Pain and Acetaminophen in Women Study". The purpose of this study is to evaluate the influence of acetaminophen on pain response and inflammation.
What is the current status of trial NCT04573426?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2019-11-15. Estimated completion is 2021-05-02.
What interventions are being tested in trial NCT04573426?
The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG), Weight stigma vignette (BEHAVIORAL), Control vignette (BEHAVIORAL).
Who is sponsoring clinical trial NCT04573426?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI